Model: | 33125-97-2 |
---|---|
Brand: | MF |
Origin: | Made In China |
Category: | Chemicals / Pharmaceutical Chemicals |
Label: | - |
Price: |
US $10
/ gram
|
Min. Order: | 5 gram |
Description
Etomidate
Etomidate structure
|
Common Name | Etomidate | ||
---|---|---|---|---|
CAS Number | 33125-97-2 | Molecular Weight | 244.289 | |
Density | 1.1±0.1 g/cm3 | Boiling Point | 391.5±17.0 °C at 760 mmHg | |
Molecular Formula | C14H16N2O2 | Melting Point | 72-74ºC | |
MSDS | Chinese USA | Flash Point | 190.6±20.9 °C | |
Symbol |
GHS07, GHS09 |
Signal Word | Warning |
Use of Etomidate
Etomidate(R-16659) is a GABAA receptors agonist, which is a short acting intravenous anaesthetic agent used for the induction of general anaesthesia.Target: GABA ReceptorEtomidate is a potent inhibitor of the adrenal response to surgery. The absence of clinical consequences associated with the blunted response s ests that a major increase in adrenal hormone production may not be necessary during surgery [1]. Etomidate is an intravenous induction agent that is associated with hemodynamic stability during intubation. The agent is therefore attractive for use in critically ill patients who have a high risk of hemodynamic instability during this procedure [2]. Etomidate use was not associated with all cause 28-day mortality or hospital mortality but was associated with significantly higher ICU mortality (91% vs. 64% for etomidate and controls groups, respectively; p = 0.02). Etomidate patients who received subsequent doses of hydrocortisone required lower doses of vasopressors and had more vasopressor-free days but no improvement in mortality [3].Clinical indications: FDA Approved Date: 1983Toxicity: Undesirable side effects of etomidate that may limit its use include pain on injection, myoclonus and adrenocortical suppression lasting 4-6 hours following an induction dose.
Etomidate Biological Activity
Description | Etomidate(R-16659) is a GABAA receptors agonist, which is a short acting intravenous anaesthetic agent used for the induction of general anaesthesia.Target: GABA ReceptorEtomidate is a potent inhibitor of the adrenal response to surgery. The absence of clinical consequences associated with the blunted response s ests that a major increase in adrenal hormone production may not be necessary during surgery [1]. Etomidate is an intravenous induction agent that is associated with hemodynamic stability during intubation. The agent is therefore attractive for use in critically ill patients who have a high risk of hemodynamic instability during this procedure [2]. Etomidate use was not associated with all cause 28-day mortality or hospital mortality but was associated with significantly higher ICU mortality (91% vs. 64% for etomidate and controls groups, respectively; p = 0.02). Etomidate patients who received subsequent doses of hydrocortisone required lower doses of vasopressors and had more vasopressor-free days but no improvement in mortality [3].Clinical indications: FDA Approved Date: 1983Toxicity: Undesirable side effects of etomidate that may limit its use include pain on injection, myoclonus and adrenocortical suppression lasting 4-6 hours following an induction dose. | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Related Catalog |
Signaling Pathways >> Membrane Transporter/Ion Channel >> GABA Receptor Signaling Pathways >> Neuronal Signaling >> GABA Receptor Research Areas >> Neurological Disease |
||||||||||||
Solvent |
In Vitro: 10 mM in DMSO |
||||||||||||
Solubility |
|
||||||||||||
Storage |
|
||||||||||||
Shipping | Room temperature in continental US; may vary elsewhere | ||||||||||||
SMILES | O=C(C1=CN=CN1[C@@H](C2=CC=CC=C2)C)OCC | ||||||||||||
References |
[1]. Griesdale, D.E., Etomidate for intubation of patients who have sepsis or septic shock - where do we go from here? Crit Care, 2012. 16(6): p. 189. [2]. Cherfan, A.J., et al., Etomidate and mortality in cirrhotic patients with septic shock. BMC Clin Pharmacol, 2011. 11: p. 22. [3]. Mehta, M.P., et al., Etomidate anesthesia inhibits the cortisol response to surgical stress. Acta Anaesthesiol Scand, 1985. 29(5): p. 486-9. |
||||||||||||
Related Molecules | (+)-Bicuculline | Picrotoxin | Aminooxyacetic acid hemihydrochloride | Riluzole | Baclofen | basmisanil | (R)-Baclofen | Etifoxine | Ginkgolide A | NS-11394 | 5alpha-Pregnan-3alpha-ol-20-one | CGP 52432 | L-655,708 | SAGE-217 | 1-(4,4-diphenyl-3-butenyl)-3-piperidinecarboxylicacidhydrochloride;SKF89976AHCl |
Chemical & Physical Properties
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 391.5±17.0 °C at 760 mmHg |
Melting Point | 72-74ºC |
Molecular Formula | C14H16N2O2 |
Molecular Weight | 244.289 |
Flash Point | 190.6±20.9 °C |
Exact Mass | 244.121185 |
PSA | 44.12000 |
LogP | 3.26 |
Vapour Pressure | 0.0±0.9 mmHg at 25°C |
Index of Refraction | 1.562 |
Storage condition | 2-8°C |
Water Solubility | DMSO: >10 mg/mL |
Handling and Storage
Precautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
Payment Terms: | TT |
---|---|
Hebei Shanghai Trading Co., Ltd | |
---|---|
Country/Region: | He Bei - China |
Business Nature: | Manufacturer |
Phone: | 17331167007 |
Contact: | Anna (sale) |
Last Online: | 17 Aug, 2022 |